E2F1

E2F1

A gene on chromosome 20q11.2 that encodes a member of the E2F family of DNA-binding transcription factors, which play a key role in regulating the cell cycle and tumour suppressor proteins. E2Fs are targets of transforming proteins of small DNA tumour viruses.
Mentioned in ?
References in periodicals archive ?
Again, there is a clear correlation between mutant P53 GOF that facilitates angiogenesis by increasing the expression of VEGF, via interaction with E2F1 that induces the expression of ID4, which in turn promotes the expression of proangiogenic factors such as IL and GROa, thus eventually leading to increasing angiogenesis in cancerous tissues.
dependent histone deacetylase (HDAC) and targets many transcription factors, such as, p53, FOXO, E2F1, NF-[kappa]B, PGC-1[alpha]:, LXR, and MyoD (Feige and Auwerx 2008).
The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis.
While HRAS, E2F1, BIRC5/survivin, and VEGFR2 were predictive for progression by univariate analysis, on multivariable analysis the combination of HRAS, VEGFR2, and VEGF expression status predicted progression with an impressive 81% sensitivity and 94% specificity.
c-Myc-regulated microRNAs modulate E2F1 expression.
It also contributes to protein stability like E2F1 and [alpha] tubulin has longer half life on acetylation (24,25).
The team demonstrated that two of these microRNAs inhibit a protein called E2F1, which regulates cell proliferation.
Revenues for both quarters related to Hoffmann-La Roche's financial support for the Company's ongoing development of products in its E2F1 Activated Checkpoint Therapy(SM) (ACT) program, which includes ARQ 501 and ARQ 171.
Enrichment of E2F1 in acetylated H3K9 promoters of TP53, BAX, PUMA, C-MYC, and C-FOS fragment precipitation was detected with antiacetylated H3K9 and anti-E2F1 antibodies.
Mutant P53 may activate a network of specific transcription factors and other target genes such as E2F1, GOF, TGFB RAS, C-Myc, NF-kB, 1D4, and E-cadherin that all contribute to accelerate tumor progression, angiogenesis, mobility, extraversion, and invasion.
miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.